Literature DB >> 17199200

[EUREGIO-projekt MRSA-net Twente/Münsterland. Creation of a regional network to combat MRSA].

I Daniels-Haardt1, F Verhoeven, A Mellmann, M G R Hendrix, J E C Gemert-Pijnen, A W Friedrich.   

Abstract

Over the last years, Germany has observed an increase in the prevalence of methicillin-resistant Staphylococcus (MRSA) in all S. aureus isolates from 2 % to about 25 % whereas in The Netherlands this proportion has continuously been kept below 1 % thanks to a consistent "search & destroy" policy. Both countries increasingly register so-called community-acquired (CA) MRSA which are a threat also to the healthy population without any known risk factor for MRSA carriership. The EUREGIO project "MRSA-net Twente/Münsterland" has made it its main goal to set up a German-Dutch network serving as a basis for a quality association which includes all those who are actively involved in health care provision on both sides of the border and to implement a coordinated strategy for MRSA control and prevention. The project is being carried out with the financial support of the European Union under the INTERREG-IIIA Community initiative and of the Ministry of Economics of the State of North Rhine-Westphalia. The epidemiological backbone of the MRSA-net is a genetic-based MRSA typing strategy (spa-typing) which has been developed by the Institute for Hygiene, University Hospital, Münster and which allows regional and cross-border comparability of laboratory results. The Faculty of Behavioural Sciences of the University of Twente examines MRSA hygiene protocols with regard to their acceptability and realisability with the intention of developing user-friendly, target group-oriented MRSA protocols for the EUREGIO. The health departments involved in the project play a central role in the coordination of the network partners in the municipalities. By performing their function of surveillance in accordance with Sections 23 and 36 of the Infectious Disease Control Act they provide an important contribution to enhancing MRSA control and prevention strategies. Thanks to its cross-border cooperation and exchange of knowledge and technology the EUREGIO project "MRSA-net" contributes to controlling the proliferation of MRSA in the EUREGIO and thus to removing obstacles to the free cross-border movement of patients and personnel.

Entities:  

Mesh:

Year:  2006        PMID: 17199200     DOI: 10.1055/s-2006-927258

Source DB:  PubMed          Journal:  Gesundheitswesen        ISSN: 0941-3790


  6 in total

1.  MRSA-surveillance in Germany: data from the Antibiotic Resistance Surveillance System (ARS) and the mandatory surveillance of MRSA in blood.

Authors:  B Schweickert; I Noll; M Feig; H Claus; G Krause; E Velasco; T Eckmanns
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2011-12-31       Impact factor: 3.267

2.  Epidemiology of MRSA and current strategies in Europe and Japan.

Authors:  Axel Kramer; Hans Wagenvoort; Christina Ahrén; Inka Daniels-Haardt; Philippe Hartemann; Hiro Kobayashi; Andrea Kurcz; Juan Picazo; Gaetano Privitera; Ojan Assadian
Journal:  GMS Krankenhhyg Interdiszip       Date:  2010-02-10

3.  Implementing the MRSA recommendations made by the Commission for Hospital Hygiene and Infection Prevention (KRINKO) of 1999 - current considerations by the DGKH Management Board.

Authors:  Arne Simon; Martin Exner; Axel Kramer; Steffen Engelhart
Journal:  GMS Krankenhhyg Interdiszip       Date:  2009-04-09

4.  Long-term persistence of MRSA in re-admitted patients.

Authors:  F Mattner; F Biertz; S Ziesing; P Gastmeier; I F Chaberny
Journal:  Infection       Date:  2010-07-03       Impact factor: 3.553

5.  Can the Hazard Assessment and Critical Control Points (HACCP) system be used to design process-based hygiene concepts?

Authors:  N-O Hübner; S Fleßa; J Haak; F Wilke; C Hübner; C Dahms; W Hoffmann; A Kramer
Journal:  GMS Krankenhhyg Interdiszip       Date:  2011-12-15

6.  Communicating the Risk of MRSA: The Role of Clinical Practice, Regulation and Other Policies in Five European Countries.

Authors:  Petra Dickmann; Sam Keeping; Nora Döring; Andrea E Schmidt; Claudia Binder; Sergio Ariño-Blasco; Joan Gil
Journal:  Front Public Health       Date:  2017-03-17
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.